The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition-Reference-Cited by-同舟云学术

The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition

Published:2021-01-11 Issue:3 Volume:64 Page:1545-1557
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mishra Sanket J.¹,Liu Weiya²,Beebe Kristin³,Banerjee Monimoy¹,Kent Caitlin N.¹,Munthali Vitumbiko¹,Koren John¹,Taylor John A²,Neckers Leonard M.³,Holzbeierlein Jeffrey²,Blagg Brian S. J.¹^ORCID

Affiliation:

1. Department of Chemistry and Biochemistry, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States

2. Department of Urologic Oncology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States

3. Center for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Rockville, Maryland 20892, United States

Funder

Division of Chemistry

National Cancer Institute

National Center for Research Resources

NIH Office of the Director

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01700

Reference43 articles.

1. Hsp90 isoforms: functions, expression and clinical importance

2. The HSP90 family of genes in the human genome: Insights into their divergence and evolution

3. Anticancer Inhibitors of Hsp90 Function

4. HSP90 and the chaperoning of cancer

5. Hsp90 interaction with clients

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity;European Journal of Medicinal Chemistry;2024-11

2. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

3. New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-07-23

4. Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design;European Journal of Medicinal Chemistry;2024-07

5. Inhibiting spinal cord-specific hsp90 isoforms reveals a novel strategy to improve the therapeutic index of opioid treatment;Scientific Reports;2024-06-26